Adherium (ASX:ADR) has launched an Early Exercise Incentive Offer that rewards eligible optionholders who subscribed under the company’s placement and accelerated non-renounceable entitlement offer.
Adherium develops connected respiratory devices and the Hailie digital platform, which enables clinicians and patients to monitor medication use and adherence. The company says more than 180,000 devices have been sold globally
The company said holders who exercise existing options by 5:00 pm (Melbourne) on 15 November 2025 will receive one new bonus option for every option exercised. Each bonus option will carry a $0.005 exercise price, an expiry of 15 November 2026, and the same terms disclosed to the Australian Stock Exchange on 26 June 2025.
While the formal entitlement remains open until 15 November, Adherium has indicated a preference for exercises lodged before 16 October, allowing allocations to be processed together in line with internal cash-flow and control considerations. Optionholders must submit the Option Exercise and Acceptance Form and ensure that cleared funds are received by the deadline. All resulting shares and bonus options will be issued concurrently to ensure no investor breaches the Corporations Act’s 19.9 per cent voting power threshold.
The early-exercise initiative follows the company’s placement and ANREO to bolster working capital and support ongoing product development and commercialisation. Adherium said investor materials, including the optionholder letter and acceptance form, are available on its website, and registrar queries should be directed to Automic Group.